Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 12/1999

01-12-1999

Six-Day or Seven-Day Regimens with Ranitidine Bismuth Citrate plus High-Dose Clarithromycin and Tinidazole Are Both Effective Against Helicobacter pylori Infection

Authors: Giovanni Cammarota, Oreste Cannizzaro, Rossella Cianci, Alessandro Armuzzi, Antonio Gasbarrini, Alfredo Pastorelli, Alfredo Papa, Giovanni Gasbarrini

Published in: Digestive Diseases and Sciences | Issue 12/1999

Login to get access
Metadata
Title
Six-Day or Seven-Day Regimens with Ranitidine Bismuth Citrate plus High-Dose Clarithromycin and Tinidazole Are Both Effective Against Helicobacter pylori Infection
Authors
Giovanni Cammarota
Oreste Cannizzaro
Rossella Cianci
Alessandro Armuzzi
Antonio Gasbarrini
Alfredo Pastorelli
Alfredo Papa
Giovanni Gasbarrini
Publication date
01-12-1999
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 12/1999
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1026658215841

Other articles of this Issue 12/1999

Digestive Diseases and Sciences 12/1999 Go to the issue

OriginalPaper

Impaired Mitogenic Response of Peripheral Blood T Cells in Ulcerative Colitis Is Not Due to Apoptosis

OriginalPaper

Case Report: Phlegmonous Gastritis Complicated by Upper Digestive Hemorrhage

OriginalPaper

Assessment of Hepatic Functional Reserve in Cirrhotic Patients by Computed Tomography of the Caudate Lobe

OriginalPaper

Cholecystectomy in Patients with Normal Gallbladder Function Did Not Alter Characteristics in Duodenal Motility Which Was Not Correlated to Size of Bile Acid Pool

OriginalPaper

Mortality and Causes of Death in Celiac Disease in a Mediterranean Area

OriginalPaper

A Synthetic Selective Inhibitor of Factor Xa, DX-9065a, Reduces Monocyte Chemoattractant Protein-1 Expression After Ischemia-Reperfusion Injury in Rat Liver
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits